Testing an eye drop to slow progression of childhood nearsightedness
Part of Eyes & vision clinical trials.
This Phase 1/2 study tests the effectiveness and safety of an investigational eye drop (IVMED-85) for myopia (nearsightedness) in children. It may help slow how quickly nearsightedness gets worse, but eligibility is limited to specific eye measurements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 5 years 6 months and 16 years 6 months old (and this study’s Phase 1 group is ages 13–16)
- Have similar nearsightedness in both eyes within a specific range (not too mild, not too severe), plus limited astigmatism and unequal eye power
- See at least 20/40 (with glasses or contacts that correct vision) in both eyes
- Have specific cornea shape and enough corneal thickness (to safely use an eye drop and measurement devices)
- Not have eye problems like cataract, glaucoma, uveitis, significant corneal scarring, or certain other eye/structural disorders
- Not have used myopia eye treatments like atropine (or similar numbing/anti-muscarinic drops) recently, and not have had certain past eye surgeries or specific contact lens use right before screening
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing the safety and comfort of new glasses with special lenses designed to slow down nearsightedness in children. It compares differences between the new lenses and regular lenses, and the child will wear them for a period of time to see how they feel and if there are any concerns.
This trial tests whether special glasses can safely slow down worsening nearsightedness (myopia) in children. If you or your child is nearsighted and interested in slowing progression, this study may be an option.
This study tests whether a very low-dose atropine eye drop (0.01%) can safely slow down worsening nearsightedness in children. It is for kids ages 3 to 12 who are already nearsighted but haven't used other myopia control treatments before.
This study tests two types of special glasses (MiYOSMART) for children with nearsightedness (myopia). The aim is to see how well they slow the progression of myopia while being comfortable and safe to wear.
This Phase 3 trial tests different doses of atropine eye drops to see which dose best slows myopia (nearsightedness) from getting worse in children. It may help by reducing how fast your child’s eyesight changes over time.
This study tests an eye drop (QLM3004) to see if it can slow down the progression of nearsightedness (myopia) in children. It might be a good option if your child is between 6 and 12, has mild to moderate nearsightedness, and hasn't used other myopia treatments before.
Hear when a new Myopia, Progressive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.